Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapyBetsy T. Kren, Janeen H. Trembley|Breast Cancer Research|2015Cited by 70
Impact of protein kinase CK2 downregulation and inhibition on oncomir clusters 17 ~ 92 and 106b ~ 25 in prostate, breast, and head and neck cancersBetsy T. Kren, Janeen H. Trembley|Molecular Medicine|2024Cited by 3